Skip to content
OpenCapital
Get started

Cato Corporation CATO Effective Income Tax Rate Reconciliation Tax Credits Research

Effective Income Tax Rate Reconciliation Tax Credits Research at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-3.4%—
Cato Corporation logo
Cato CorporationCATO
-2.2%-3.5pp
Whirlpool logo
WhirlpoolWHR
4.1%—
ICF International logo
ICF InternationalICFI
9.2%-1.6pp
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-2%-0.6pp
Avanos Medical logo
Avanos MedicalAVNS
-2.3%-3.2pp

Other financials

Income statement

See full
Revenue$171.1M+0.5%
Gross profit$64.8M+6.3%
Operating income$9.0M+160%
Net income$9.3M+181%
EPS (diluted)$0.47+176%

Balance sheet

See full
Cash & equivalents$28.1M-17.4%
Total debt$145.0M+9.4%
Total equity$166.7M+1.1%
Total assets$439.2M-0.4%

Cash flow

See full
Operating cash flow$8.0M+108%
CapEx$1.1M+4.7%
Free cash flow$7.0M+145%

Valuation

See full
Market cap$64.67M+18.3%
Enterprise value$181.61M+18.5%
P/E710.6×—
P/S0.1×0.0×

Profitability

See full
Gross margin34.5%+1.9pp
Operating margin-1.1%-0.5pp
Net margin0%0.0pp
FCF margin-0.2%-0.1pp

Returns & leverage

See full
Return on equity0.1%0.0pp
Debt / equity0.9×+0.1×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Cato Corporation in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch.

The official record: Cato Corporation’s 10-K, filed March 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cato Corporation's effective income tax rate reconciliation tax credits research.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cato Corporation's effective income tax rate reconciliation tax credits research?
Cato Corporation (CATO) reported effective income tax rate reconciliation tax credits research of -2.2% in Q4 2025.
What does effective income tax rate reconciliation tax credits research mean?
Measures the percentage point reduction in the effective income tax rate attributable to research and development tax credits. It provides insight into the relative efficiency of the company's tax planning strategies regarding R&D investment.